In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.

AUTOR(ES)

Tai, M

RESUMO

The activities of T-1982 (sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazine-carboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate) against various gram-positive and gram-negative bacteria were compare with those of cefmetazole, cefoxitin, cefazolin, and cefoperazone. T-1982 was active against both gram-positive and gram-negative bacteria, including genera resistant to the other cephalosporins. T-1982 exhibited greater activity than did cefmetazole, cefoxitin, cefazolin, or cefoperazone against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Serratia marcescens and was also highly active against Bacteroides fragilis. T-1982 was as stable to various beta-lactamases as were cefmetazole and cefoxitin. The therapeutic activities of T-1982 in mice experimentally infected with various gram-negative bacteria were superior to those of cefmetazole, cefoxitin, cefazolin, and cefoperazone.

Documentos Relacionados

• In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.
• In Vitro and In Vivo Antibacterial Activity of T-1220, a New Semisynthetic Penicillin
• In vitro antibacterial activity of KP-736, a new cephem antibiotic.
• Maridomycin, a New Macrolide Antibiotic. In Vitro Antibacterial Activity of 9-Propionylmaridomycin
• In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic.